Tiziana Life Sciences Ltd (TLSA) Stock Forecast
TLSA analyst forecast
as of October 17, 2026- Analyst consensus
- Strong buy 5.00 / 5 from 2 analysts
- Price target
- $8.06 average of analyst targets
- Upside to target
- +667.3% from the latest close
- Next earnings
- —
- 52-week range
- $0.77 – $1.96
TLSA analyst ratings
2 analystsNumber of analysts at each rating.
TLSA price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
TLSA earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Current fiscal year (2026) | −$0.13 | −$0.14 | −$0.12 | −$0.12 | −9.4% | 2 |
| Next fiscal year (2027) | −$0.14 | −$0.14 | −$0.14 | −$0.13 | −5.8% | 1 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
TLSA revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Current fiscal year (2026) | $0 | $0 | $0 | 0.0% | 2 |
| Next fiscal year (2027) | $0 | $0 | $0 | 0.0% | 1 |
TLSA EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
TLSA EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Current fiscal year (2026) | −$0.12 | −$0.12 | −$0.12 | −$0.12 | −$0.13 | +6.2% | 0 up · 1 down |
| Next fiscal year (2027) | $0.00 | $0.00 | $0.00 | $0.00 | −$0.14 | — | 0 up · 0 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
TLSA earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; TLSA beat in 4 of 11.
What analysts expect from TLSA
2 analysts cover Tiziana Life Sciences; their consensus rating is strong buy (5.00 on a 1–5 scale, where 5 is a strong buy). The average price target is $8.06, 667.3% above the latest close of $1.05. Analysts expect earnings of −$0.13 per share for 2026, −9.4% from a year earlier. For 2027 the average estimate is −$0.14 per share. Tiziana Life Sciences beat the EPS estimate in 4 of the last 11 quarters.
Related: TLSA income statement, TLSA key metrics, TLSA chart. See the TLSA stock overview for the latest quote and news.
TLSA forecast FAQ
What is Tiziana Life Sciences's price target?
The average analyst price target for Tiziana Life Sciences is $8.06, 667.3% above the latest close of $1.05.
Is Tiziana Life Sciences a buy, hold or sell?
Of 2 analysts covering Tiziana Life Sciences, 2 rate it a strong buy, 0 a buy, 0 a hold, 0 a sell and 0 a strong sell, a consensus of strong buy. Ratings are opinions, not a recommendation from Quotelinks.
What is Tiziana Life Sciences's EPS forecast?
Analysts forecast −$0.13 per share for 2026 (range −$0.14 to −$0.12); for 2027 the estimate is −$0.14.
Does Tiziana Life Sciences usually beat earnings estimates?
Tiziana Life Sciences reported EPS at or above the analyst estimate in 4 of the last 11 quarters.